1325 related articles for article (PubMed ID: 23892895)
1. RNA-guided gene activation by CRISPR-Cas9-based transcription factors.
Perez-Pinera P; Kocak DD; Vockley CM; Adler AF; Kabadi AM; Polstein LR; Thakore PI; Glass KA; Ousterout DG; Leong KW; Guilak F; Crawford GE; Reddy TE; Gersbach CA
Nat Methods; 2013 Oct; 10(10):973-6. PubMed ID: 23892895
[TBL] [Abstract][Full Text] [Related]
2. CRISPR RNA-guided activation of endogenous human genes.
Maeder ML; Linder SJ; Cascio VM; Fu Y; Ho QH; Joung JK
Nat Methods; 2013 Oct; 10(10):977-9. PubMed ID: 23892898
[TBL] [Abstract][Full Text] [Related]
3. Cas9 as a versatile tool for engineering biology.
Mali P; Esvelt KM; Church GM
Nat Methods; 2013 Oct; 10(10):957-63. PubMed ID: 24076990
[TBL] [Abstract][Full Text] [Related]
4. Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system.
Cheng AW; Wang H; Yang H; Shi L; Katz Y; Theunissen TW; Rangarajan S; Shivalila CS; Dadon DB; Jaenisch R
Cell Res; 2013 Oct; 23(10):1163-71. PubMed ID: 23979020
[TBL] [Abstract][Full Text] [Related]
5. Engineering synthetic TALE and CRISPR/Cas9 transcription factors for regulating gene expression.
Kabadi AM; Gersbach CA
Methods; 2014 Sep; 69(2):188-97. PubMed ID: 25010559
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9-mediated genome editing of Epstein-Barr virus in human cells.
Yuen KS; Chan CP; Wong NM; Ho CH; Ho TH; Lei T; Deng W; Tsao SW; Chen H; Kok KH; Jin DY
J Gen Virol; 2015 Mar; 96(Pt 3):626-636. PubMed ID: 25502645
[TBL] [Abstract][Full Text] [Related]
7. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
8. RNA-guided genome editing à la carte.
Horvath P; Barrangou R
Cell Res; 2013 Jun; 23(6):733-4. PubMed ID: 23478298
[TBL] [Abstract][Full Text] [Related]
9. Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
Grenier F; Lucier JF; Rodrigue S
Methods Mol Biol; 2015; 1334():233-44. PubMed ID: 26404154
[TBL] [Abstract][Full Text] [Related]
10. A CRISPR view of development.
Harrison MM; Jenkins BV; O'Connor-Giles KM; Wildonger J
Genes Dev; 2014 Sep; 28(17):1859-72. PubMed ID: 25184674
[TBL] [Abstract][Full Text] [Related]
11. A Genome-Editing Nanomachine Constructed with a Clustered Regularly Interspaced Short Palindromic Repeats System and Activated by Near-Infrared Illumination.
Peng H; Le C; Wu J; Li XF; Zhang H; Le XC
ACS Nano; 2020 Mar; 14(3):2817-2826. PubMed ID: 32048826
[TBL] [Abstract][Full Text] [Related]
12. Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos.
Chang N; Sun C; Gao L; Zhu D; Xu X; Zhu X; Xiong JW; Xi JJ
Cell Res; 2013 Apr; 23(4):465-72. PubMed ID: 23528705
[TBL] [Abstract][Full Text] [Related]
13. RNA-guided genome editing for target gene mutations in wheat.
Upadhyay SK; Kumar J; Alok A; Tuli R
G3 (Bethesda); 2013 Dec; 3(12):2233-8. PubMed ID: 24122057
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas-mediated targeted genome editing in human cells.
Yang L; Mali P; Kim-Kiselak C; Church G
Methods Mol Biol; 2014; 1114():245-67. PubMed ID: 24557908
[TBL] [Abstract][Full Text] [Related]
15. Repurposing CRISPR System for Transcriptional Activation.
Chen M; Qi LS
Adv Exp Med Biol; 2017; 983():147-157. PubMed ID: 28639197
[TBL] [Abstract][Full Text] [Related]
16. Optical Control of CRISPR/Cas9 Gene Editing.
Hemphill J; Borchardt EK; Brown K; Asokan A; Deiters A
J Am Chem Soc; 2015 May; 137(17):5642-5. PubMed ID: 25905628
[TBL] [Abstract][Full Text] [Related]
17. Current and future delivery systems for engineered nucleases: ZFN, TALEN and RGEN.
Ul Ain Q; Chung JY; Kim YH
J Control Release; 2015 May; 205():120-7. PubMed ID: 25553825
[TBL] [Abstract][Full Text] [Related]
18. The CRISPR Growth Spurt: from Bench to Clinic on Versatile Small RNAs.
Bayat H; Omidi M; Rajabibazl M; Sabri S; Rahimpour A
J Microbiol Biotechnol; 2017 Feb; 27(2):207-218. PubMed ID: 27840399
[TBL] [Abstract][Full Text] [Related]
19. Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch.
Oakes BL; Nadler DC; Flamholz A; Fellmann C; Staahl BT; Doudna JA; Savage DF
Nat Biotechnol; 2016 Jun; 34(6):646-51. PubMed ID: 27136077
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9 Immune System as a Tool for Genome Engineering.
Hryhorowicz M; Lipiński D; Zeyland J; Słomski R
Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):233-240. PubMed ID: 27699445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
